Goodwin Procter LLP advised Doximity on the deal. Doximity (NYSE: DOCS) announced its initial public offering of 23,300,000 shares of its Class A common stock at a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Rubius Therapeutics on the deal. Rubius Therapeutics (NASDAQ: RUBY) announced the upsized underwritten public offering of 6,896,552 shares of its common stock at...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins LLP advised TPG Pace Tech Opportunities on the deal while Goodwin Procter LLP advised Nerdy Inc. on the deal. TPG Pace Tech Opportunities...
You must be a Standard 1 Year member to access this content.
